PapersPMID:33347024
No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.
- 01 · finding
- 1
- 02 · compound
- 1
- 03 · endpoint
- 1
- 04 · null
- 0
What it reported
How to read these marksWhat moved
1 finding
coenzyme Q10 — increases circulating coenzyme Q10 concentration
Evidence strength: very limited.Findingreplicated ×1“At 3 months, CoQ10 concentration was significantly higher in the CoQ10 group (3.85 μg/mL) compared with placebo (1.13 μg/mL); this difference was not present at 6 months.”
Quoted verbatim from No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.. - Study
- RCT
- Dose
- 300 mg/day
- Population
- adults with schizophrenia or schizoaffective disorder, CoQ10 300 mg/day vs placebo; measured at 3 months (difference not present at 6 months)
No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.2020PMID:3334702410.1097/JCP.0000000000001330Permalink
Study record
Read under: coenzyme Q10
- Design
- randomised controlled trial
- Species
- human
- Population
- adults with schizophrenia or schizoaffective disorder, CoQ10 300 mg/day vs placebo; measured at 3 months (difference not present at 6 months)
- Participants
- not recorded
- Comparator
- not stated in the paper
- Duration
- not recorded
- Endpoints
- 8
- Record
- extracted
- Readings recorded
- 2